These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32768645)

  • 1. Selective thyroid hormone receptor β agonists with oxadiazolone acid isosteres.
    Kirschberg TA; Jones CT; Xu Y; Fenaux M; Halcomb RL; Wang Y; Klucher K
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127465. PubMed ID: 32768645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonists: importance of liver selectivity in drug discovery.
    Takahashi N; Asano Y; Maeda K; Watanabe N
    Biol Pharm Bull; 2014; 37(7):1103-8. PubMed ID: 24989002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH).
    Luong XG; Stevens SK; Jekle A; Lin TI; Gupta K; Misner D; Chanda S; Mukherjee S; Williams C; Stoycheva A; Blatt LM; Beigelman LN; Symons JA; Raboisson P; McGowan D; Vandyck K; Deval J
    PLoS One; 2020; 15(12):e0240338. PubMed ID: 33306682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists.
    Burkholder TP; Cunningham BE; Clayton JR; Lander PA; Brown ML; Doti RA; Durst GL; Montrose-Rafizadeh C; King C; Osborne HE; Amos RM; Zink RW; Stramm LE; Burris TP; Cardona G; Konkol DL; Reidy C; Christe ME; Genin MJ
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1377-80. PubMed ID: 25752984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.
    Erion MD; Cable EE; Ito BR; Jiang H; Fujitaki JM; Finn PD; Zhang BH; Hou J; Boyer SH; van Poelje PD; Linemeyer DL
    Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15490-5. PubMed ID: 17878314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
    Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
    J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo activity of the thyroid hormone receptor beta- and α-selective agonists GC-24 and CO23 on rat liver, heart, and brain.
    Grijota-Martínez C; Samarut E; Scanlan TS; Morte B; Bernal J
    Endocrinology; 2011 Mar; 152(3):1136-42. PubMed ID: 21239431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats.
    Perra A; Simbula G; Simbula M; Pibiri M; Kowalik MA; Sulas P; Cocco MT; Ledda-Columbano GM; Columbano A
    FASEB J; 2008 Aug; 22(8):2981-9. PubMed ID: 18434432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β agonist in clinical trials for the treatment of dyslipidemia.
    Kelly MJ; Pietranico-Cole S; Larigan JD; Haynes NE; Reynolds CH; Scott N; Vermeulen J; Dvorozniak M; Conde-Knape K; Huang KS; So SS; Thakkar K; Qian Y; Banner B; Mennona F; Danzi S; Klein I; Taub R; Tilley J
    J Med Chem; 2014 May; 57(10):3912-23. PubMed ID: 24712661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists.
    Horan JC; Sanyal S; Choi Y; Hill-Drzewi M; Patnaude L; Anderson S; Fogal S; Mao C; Cook BN; Gueneva-Boucheva K; Fisher MB; Hickey E; Pack E; Bannen LC; Chan DS; Mac MB; Ng SM; Wang Y; Xu W; Modis LK; Lemieux RM
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4807-11. PubMed ID: 25241927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac specific effects of thyroid hormone analogues.
    Danzi S; Klein I
    Horm Metab Res; 2011 Oct; 43(11):737-42. PubMed ID: 22009366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and methemoglobinemia-inducing properties of benzocaine isosteres designed as humane rodenticides.
    Conole D; Beck TM; Jay-Smith M; Tingle MD; Eason CT; Brimble MA; Rennison D
    Bioorg Med Chem; 2014 Apr; 22(7):2220-35. PubMed ID: 24602400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2.
    DiMauro EF; Buchanan JL; Cheng A; Emkey R; Hitchcock SA; Huang L; Huang MY; Janosky B; Lee JH; Li X; Martin MW; Tomlinson SA; White RD; Zheng XM; Patel VF; Fremeau RT
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4267-74. PubMed ID: 18640038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration.
    Perra A; Kowalik MA; Cabras L; Runfola M; Sestito S; Migliore C; Giordano S; Chiellini G; Rapposelli S; Columbano A
    Cell Prolif; 2020 May; 53(5):e12808. PubMed ID: 32347601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Structure-Activity Relationship (SAR) of potent and selective oxadiazole-based agonists of sphingosine-1-phosphate receptor (S1P
    Liu T; Jin J; Chen Y; Xi Q; Hu J; Jia W; Chen X; Li Y; Wang X; Yin D
    Bioorg Chem; 2019 Feb; 82():41-57. PubMed ID: 30268973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological characterization of 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonists.
    Takahashi N; Maeda K; Asano Y; Watanabe N
    Bioorg Med Chem; 2014 Jan; 22(1):488-98. PubMed ID: 24290064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity.
    Lee SH; Seo HJ; Lee SH; Jung ME; Park JH; Park HJ; Yoo J; Yun H; Na J; Kang SY; Song KS; Kim MA; Chang CH; Kim J; Lee J
    J Med Chem; 2008 Nov; 51(22):7216-33. PubMed ID: 18954042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and structure-activity relationship (SAR) of N-[7-(4-hydroxyphenoxy)-6-methylindan-4-yl]malonamic acids as thyroid hormone receptor β (TRβ) selective agonists.
    Shiohara H; Nakamura T; Kikuchi N; Ozawa T; Matsuzawa A; Nagano R; Ohnota H; Miyamoto T; Ichikawa K; Hashizume K
    Bioorg Med Chem; 2013 Feb; 21(3):592-607. PubMed ID: 23276448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperazine oxadiazole inhibitors of acetyl-CoA carboxylase.
    Bourbeau MP; Siegmund A; Allen JG; Shu H; Fotsch C; Bartberger MD; Kim KW; Komorowski R; Graham M; Busby J; Wang M; Meyer J; Xu Y; Salyers K; Fielden M; Véniant MM; Gu W
    J Med Chem; 2013 Dec; 56(24):10132-41. PubMed ID: 24294923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and optimization of 5-(2-((1-(phenylsulfonyl)-1,2,3,4-tetrahydroquinolin-7-yl)oxy)pyridin-4-yl)-1,2,4-oxadiazoles as novel gpr119 agonists.
    Wang Y; Yu M; Zhu J; Zhang JK; Kayser F; Medina JC; Siegler K; Conn M; Shan B; Grillo MP; Liu JJ; Coward P
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1133-7. PubMed ID: 24440299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.